{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Pennington",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "77674",
      "recalling_firm": "Zydus Pharmaceuticals USA Inc",
      "address_1": "73 Route 31 N",
      "address_2": "N/A",
      "postal_code": "08534-3601",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1041-2017",
      "product_description": "Divalproex Sodium Delayed Release Tablets, USP,  125 mg, 100-count bottle Rx only, Manufactured by Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals, Pennington, NJ 07054, NDC 68382-031-01",
      "product_quantity": "108,096 HDPE bottles",
      "reason_for_recall": "Failed Dissolution Specifications",
      "recall_initiation_date": "20170510",
      "center_classification_date": "20170731",
      "termination_date": "20200107",
      "report_date": "20170809",
      "code_info": "MR6317 Exp.05/17  MR6318 Exp. 05/17  MR6319 Exp. 05/17  MR5361 Exp. 06/17  MR9007 Exp. 08/17  MR10000 Exp. 08/17  MR10923 Exp. 10/17  MR10924 Exp. 10/17  MR10925 Exp. 10/17  MR11554 Exp. 11/17  MR11555 Exp. 11/17  MS1359 Exp. 12/17"
    }
  ]
}